Abbott. 2.2.1 Abbott will manufacture two (2) batches of ▇▇▇▇ Product under GMP co▇▇▇▇▇▇ns for human use including mixing of raw materials and extrusion. 2.2.2 In parallel with the above step 2.2.1, Abbott will also perform [**] 2.2.3 Abbott will carry ▇▇▇ ▇▇ort term stability testing of the two (2) ba▇▇▇▇▇ of Bulk Product obtained under step 2.2.1 above [**] according to ICH conditions in bulk container packaging material. [**]
Appears in 1 contract
Sources: Development and Supply Agreement (Barrier Therapeutics Inc)
Abbott. 2.2.1 Abbott will manufacture two (2) batches of ▇▇▇▇ Bulk Product under GMP co▇▇▇▇▇▇ns conditions for human use including mixing of raw materials and extrusion.
2.2.2 In parallel with the above step 2.2.1, Abbott will also perform [**]
2.2.3 Abbott will carry ▇▇▇ ▇▇ort out short term stability testing of the two (2) ba▇▇▇▇▇ batches of Bulk Product obtained under step 2.2.1 above [**] according to ICH conditions in bulk container packaging material. [**]
Appears in 1 contract
Sources: Development and Supply Agreement (Barrier Therapeutics Inc)